#pharmanews is an active hashtag on Bluesky. In the last 30 days, 8 people shared 31 posts with it — around 1 a day. Activity is up 120% versus the previous week, peaking on Jul 17 with 3 posts.
biotechstockdaily.com
Inside the inMIND Trial Data Behind Minjuvi's New PBS Listing - BioTech Stocks Daily
Specialised Therapeutics (ST), a Singapore-headquartered specialty pharmaceutical company, announced in a press release on August 2 that Minjuvi (tafasitamab), used together with rituximab and lenalid...
cinquewnews.blogspot.com
Biogen probed by Italy over MS drug competition
Italy probes Biogen over alleged attempts to block Sandoz’s MS biosimilar and limit competition in natalizumab drugs.
pharmaphorum.com
Sources quash rumours of an AZ/BMS mega-merger
A media report suggests there is no substance to the rumours of a $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb.
umlegacypressqsefc.com
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale: Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation. #AstraZeneca #BristolMyersSquibb #PharmaNews #BigPharma #MergerTalks
pharmaphorum.com
Are we about to see a return for the pharma mega-merger?
There are rumours that the first pharma 'mega-merger' for several years – between AstraZeneca and Bristol Myers Squibb – is under discussion.
pharmaphorum.com
Sources quash rumours of an AZ/BMS mega-merger
A media report suggests there is no substance to the rumours of a $400 billion mega-merger between AstraZeneca and Bristol Myers Squibb.
umlegacypressqsefc.com
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale: Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation. #AstraZeneca #BristolMyersSquibb #PharmaNews #BigPharma #MergerTalks
pharmaphorum.com
Are we about to see a return for the pharma mega-merger?
There are rumours that the first pharma 'mega-merger' for several years – between AstraZeneca and Bristol Myers Squibb – is under discussion.
eslammsd-tech-gaming-trends.static.hf.space
AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
Tech Gaming Trends
biotechstockdaily.com
Inside the inMIND Trial Data Behind Minjuvi's New PBS Listing - BioTech Stocks Daily
Specialised Therapeutics (ST), a Singapore-headquartered specialty pharmaceutical company, announced in a press release on August 2 that Minjuvi (tafasitamab), used together with rituximab and lenalid...
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.